0044sek
3,5 %
Date:2025-05-13Time:18:00:00Latest report:Q1-2025List:Small CapTicker:QLINEA
Market Cap:196 msekEnterprise Value:179 msekNet Sales:4,57 msekEarnings:-206,1 msekEmployees:0ISIN:SE0011527845

Ratios

10-year key figure history for Q-Linea turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Q-Linea with index and moving average MA50 and MA200.

Stockprice:0,044
MA50:0,04
MA200:1,41
Price/MA200:-96,9 %
RSI (14):59,6
Price/MA50:8,2 %

Description

Q-Linea operates in the medical technology sector. The company specializes in research and development of instruments and consumables. The products are mainly used in the treatment of infectious diseases and blood poisoning, and include diagnostic and analytical tools, as well as basic sample handling. The technology is based on the so-called ID and AST technology. Q-Linea was founded in 2008 and is headquartered in Uppsala.

Medical Equipment